Financial Shenanigans

The Forensic Verdict

Vedanta earns an Elevated forensic risk score of 58/100: the reported numbers are cash-backed at the consolidated level, but they require a valuation haircut for parent-related-party complexity, recurring exceptional items, and asset recoverability judgments. The two biggest concerns are the VRL/related-party cash ecosystem and the oil/power accounting judgments embedded in impairment reversals, disputed receivables, and arbitration-linked benefits. The cleanest offset is cash conversion: the latest three reported years show CFO at 2.16x net income and FCF at 1.14x net income, with FY2025 receivables growing slower than revenue. The one data point that would most change the grade is independent evidence that VRL-group loans, brand fees, guarantees, and dividend funding no longer pressure VEDL cash flows or disclosures.

Breeding Ground

The breeding ground amplifies the accounting risk because Vedanta combines promoter control, material related-party flows, complex group financing, and high-judgment assets, even though the audit committee and FY2025 audit opinion provide real offsets.

The board had eight directors at 31 March 2025, with four independent directors and an Audit & Risk Management Committee described as composed only of independent directors. That is a governance offset. The pressure point is control: promoters held 56.38% at 31 March 2026, VEDL is majority-controlled through VRL, and FY2025 related-party notes show management and brand fees of ₹30.39bn on a consolidated basis (₹26.98bn in the standalone related-party table), dividends to holding companies of ₹96.98bn, and a VRL-group loan with contractual value of ₹35.67bn whose maturity was extended and rate reduced from 17.0% to 13.5%.

The auditor side is mixed. S.R. Batliboi issued an unmodified FY2025 opinion, the directors' report says the statutory and secretarial audit reports had no qualifications, and auditors reported no fraud by the company or material fraud in the company. The yellow flag is controls hygiene: the FY2025 notes state the SAP audit trail for direct changes to certain database tables was enabled only from 3 March 2025, although no tampering was noted.

Earnings Quality

Earnings quality is acceptable on revenue collection but weak on normalization because special items, disputed receivables, impairment reversals, and deferred tax recoverability carry too much of the interpretation load.

The core revenue test is clean. FY2025 trade receivables were ₹60.87bn versus ₹60.16bn in FY2024, while reported revenue rose 6.4%; debtor days stayed at 9. Unbilled dues were only ₹1.0bn, so the balance sheet does not show the usual pattern of revenue being pulled forward into receivables or contract assets.

Management's preferred earnings lens is not neutral. FY2024 included a ₹47.61bn revenue benefit tied to the Rajasthan oil and gas arbitration award, while FY2025 exceptional items included a ₹23.58bn gross impairment reversal in the Rajasthan Oil & Gas block. In FY2026, management reported ₹285.94bn PAT before exceptional items versus ₹250.96bn reported PAT after ₹34.98bn of net exceptional charges.

The main clean negative evidence is that revenue does not outrun customer cash collection. The main adverse evidence is that a meaningful share of the earnings story rests on legal awards, impairment models, and recoverability judgments rather than low-judgment operating conversion.

Cash Flow Quality

Cash flow quality is the strongest part of the forensic picture: Vedanta generates real operating cash, and FY2025 cash flow was not inflated by stretching suppliers.

The latest three reported fiscal years produced ₹1,147.15bn of CFO against ₹531.70bn of net income. That is not a classic earnings-quality warning. The caveat is capital intensity: FCF after capex is materially lower than CFO, and management's pre-capex framing is not distributable cash.

FY2025 working capital was a ₹6.65bn cash drag, not a lifeline. Receivable collections added ₹55.53bn, but inventory consumed ₹17.14bn and lower trade and other payables consumed ₹45.04bn. DPO also fell to 76 days from 83 days, so strong CFO was not produced by paying suppliers slower.

The cash-flow risk is presentation, not existence. FY2025 capex was 1.51x depreciation and CWIP rose to ₹338.96bn, so post-capex FCF is the right valuation anchor. FY2026 depreciation is less comparable because management said Q4 FY2026 D&A was lower due to Ind AS 105 accounting after the NCLT demerger order.

Metric Hygiene

Metric hygiene is weak because management repeatedly asks investors to look at adjusted EBITDA, PAT before exceptional items, pre-capex FCF, and perimeter-specific leverage while the adjustments are economically important.

The short version is that EBITDA is useful for commodity-cycle attribution, but PAT before exceptional items and pre-capex FCF are too generous for valuation. The most important balance-sheet hygiene issue is perimeter: VEDL may show lower net debt / EBITDA while the controlling parent still has separate financing needs and related-party channels into VEDL.

What to Underwrite Next

The next underwriting work is concentrated in the few disclosures that can actually move the forensic grade, not generic accounting checklists.

This is not a thesis breaker today because reported cash generation is strong, DSO is clean, and the FY2025 audit opinion is unmodified. It is also not a footnote: related-party economics, recurring exceptional items, and high-judgment assets belong in valuation, position sizing, covenant comfort, and required margin of safety until cash flows to and from the parent group become simpler and the oil/power legal exposures resolve in cash.